<span id="midArticle_start"/>May 28Pharmstandart :
<span id="midArticle_0"/>* Says has received 52 pct stake in MasterPlazma LLCSourcetext: bit.ly/1HygTUZ
<span id="midArticle_1"/> <span class="first-article-divide"/>Further company coverage:
<span id="midArticle_2"/> <span class="second-article-divide"/> <span class="third-article-divide"/>(Gdynia Newsroom)
<span id="midArticle_3"/>
<span id="midArticle_0"/>* Says has received 52 pct stake in MasterPlazma LLCSourcetext: bit.ly/1HygTUZ
<span id="midArticle_1"/> <span class="first-article-divide"/>Further company coverage:
<span id="midArticle_2"/> <span class="second-article-divide"/> <span class="third-article-divide"/>(Gdynia Newsroom)
<span id="midArticle_3"/>
via Smart Health Shop Forum http://ift.tt/1dAfK8e
No comments:
Post a Comment